Ditte Rask Tornby

Ditte Rask Tornby is a researcher affiliated with the Department of Clinical Research at the University of Southern Denmark and the Research Unit of Clinical Microbiology (Odense). Her work focuses on virology, clinical microbiology, and antimicrobial strategies.

• University: University of Southern Denmark
• Department: Research Unit of Clinical Microbiology (Odense)

Her research spans SARS-CoV-2 variants, vaccine efficacy in immunocompromised populations, fungal pathogenesis, and antimicrobial biomaterial development. Recent work includes protocols for viral culturing, neutralization studies in kidney transplant recipients, and biosynthesis of fungal metabolites.

Publications highlight interdisciplinary collaborations in virology (SARS-CoV-2 Omicron/Delta neutralization), mycology (Aspergillus californicus), and biomedical engineering (antibiotic-loaded polymer networks).

She works with the COVAC-TX Study Group and collaborators at Odense University Hospital (OUH) and Karolinska Institutet (KI).